Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease
- PMID: 33484772
- DOI: 10.1016/j.jhep.2021.01.016
Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease
Keywords: C-reactive protein; acute-on-chronic liver failure; ascites; cirrhosis.
Conflict of interest statement
Conflict of interest The authors have nothing to declare regarding this manuscript. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment in
-
Reply to: "Presepsin as a biomarker of inflammation and prognosis in decompensated liver disease".J Hepatol. 2021 Jul;75(1):234-236. doi: 10.1016/j.jhep.2021.03.027. Epub 2021 Apr 20. J Hepatol. 2021. PMID: 33852949 No abstract available.
Comment on
-
Systemic inflammation increases across distinct stages of advanced chronic liver disease and correlates with decompensation and mortality.J Hepatol. 2021 Apr;74(4):819-828. doi: 10.1016/j.jhep.2020.10.004. Epub 2020 Oct 16. J Hepatol. 2021. PMID: 33075344
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
